Literature DB >> 3472676

Relative cardiotoxicity and cytotoxicity of anthraquinonyl glucosaminosides.

J W Banning, H N Abramson, H C Wormser, J D Wu, T H Corbett.   

Abstract

The cardiotoxicity and cytotoxicity for tumor cells of four new synthetic anthraquinonyl glucosaminosides were compared in vitro. The nonhydroxylated anthraquinone was not cardiotoxic, and its cytotoxic activity was the weakest of the compounds in the series. Increasing the number of hydroxyl groups on the anthraquinone moiety increased the inhibition of growth of L-1210 leukemia cells and pancreatic or colonic adenocarcinomas in a soft agar colony formation assay. However, cardiotoxicity was also increased in proportion to the number of hydroxyl groups present. The adenocarcinomas were slightly more sensitive than the leukemias to the inhibitory action of the dihydroxylated anthraquinonyl glucosaminosides on cell growth.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472676     DOI: 10.1007/BF00252974

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  12 in total

1.  Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents.

Authors:  J W Lown; H H Chen; J A Plambeck; E M Acton
Journal:  Biochem Pharmacol       Date:  1979-09-01       Impact factor: 5.858

2.  Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.

Authors:  B T Hill; L Y Dennis; X T Li; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Direct effects of adriamycin on the rat heart sarcolemma.

Authors:  P K Singal; V Panagia
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1984-01

Review 4.  The mechanism of action of quinone antibiotics.

Authors:  J W Lown
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

5.  Experimental evaluation of anthracycline analogs.

Authors:  A M Casazza
Journal:  Cancer Treat Rep       Date:  1979-05

6.  Effect of anthracycline antibiotics on oxygen radical formation in rat heart.

Authors:  J H Doroshow
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

Review 7.  Animal models of drug-induced cardiomyopathy.

Authors:  C M Czarnecki
Journal:  Comp Biochem Physiol C Comp Pharmacol Toxicol       Date:  1984

8.  Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.

Authors:  T H Corbett; M C Bissery; A Wozniak; J Plowman; L Polin; E Tapazoglou; J Dieckman; F Valeriote
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

9.  Early anthracycline cardiotoxicity.

Authors:  M R Bristow; P D Thompson; R P Martin; J W Mason; M E Billingham; D C Harrison
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

10.  Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pig.

Authors:  W E Perkins; R L Schroeder; R A Carrano; A R Imondi
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

View more
  1 in total

Review 1.  Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  L M Hollingshead; D Faulds
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.